Octavio Marquez - 12 May 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
President and CEO, Director
Signature
Jonathan B. Leiken, Attorney-in-fact for Octavio Marquez
Issuer symbol
DBD
Transactions as of
12 May 2022
Net transactions value
+$110,637
Form type
4
Filing time
12 May 2022, 10:32:11 UTC
Previous filing
16 Mar 2022
Next filing
01 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Purchase $48,590 +21,500 +7.8% $2.26* 298,428 12 May 2022 Direct F1
transaction DBD Common Shares Purchase $12,085 +5,371 +1.8% $2.25* 303,799 12 May 2022 Direct F1
transaction DBD Common Shares Purchase $46,558 +20,420 +6.7% $2.28* 324,219 12 May 2022 Direct F1
transaction DBD Common Shares Purchase $3,405 +1,500 +0.46% $2.27* 325,719 12 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option 15,885 12 May 2022 Common Shares 15,885 $34.13 Direct F2
holding DBD Non-Qualified Stock Option 22,735 12 May 2022 Common Shares 22,735 $32.33 Direct F2
holding DBD Non-Qualified Stock Option 16,388 12 May 2022 Common Shares 16,388 $27.39 Direct F2
holding DBD Non-Qualified Stock Option 37,996 12 May 2022 Common Shares 37,996 $26.60 Direct F3
holding DBD Non-Qualified Stock Option 19,786 12 May 2022 Common Shares 19,786 $18.75 Direct F3
holding DBD Non-Qualified Stock Option 33,843 12 May 2022 Common Shares 33,843 $4.08 Direct F3
holding DBD Non-Qualified Stock Option 9,327 12 May 2022 Common Shares 9,327 $11.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Number includes restricted stock units.
F2 Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F3 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.